bethanechol has been researched along with Chronic Disease in 8 studies
Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The esophageal pH probe identifies gastroesophageal reflux." | 2.38 | Chronic pulmonary aspiration in children. ( Bauer, ML; Figueroa-Colon, R; Georgeson, K; Young, DW, 1993) |
| "They have been of value in treating pain of cancer and spasticity through spinal subarachnoid catheters." | 2.37 | Drug pumps for treatment of neurologic diseases and pain. ( Penn, RD, 1985) |
| "We report a case of neurogenic bladder and chronic urinary retention associated with MDMA abuse." | 1.35 | Neurogenic bladder and chronic urinary retention associated with MDMA abuse. ( Barrueto, F; Beuerle, JR, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hardwick, JC | 1 |
| Ryan, SE | 1 |
| Beaumont, E | 1 |
| Ardell, JL | 1 |
| Southerland, EM | 1 |
| Beuerle, JR | 1 |
| Barrueto, F | 1 |
| Björnsson, ES | 1 |
| Chey, WD | 1 |
| Hooper, F | 1 |
| Woods, ML | 1 |
| Owyang, C | 1 |
| Hasler, WL | 1 |
| Goldstein, DS | 1 |
| Holmes, C | 1 |
| Dendi, R | 1 |
| Li, ST | 1 |
| Brentzel, S | 1 |
| Vernino, S | 1 |
| Bauer, ML | 1 |
| Figueroa-Colon, R | 1 |
| Georgeson, K | 1 |
| Young, DW | 1 |
| Kato, K | 1 |
| Monson, FC | 1 |
| Longhurst, PA | 1 |
| Wein, AJ | 1 |
| Haugaard, N | 1 |
| Levin, RM | 1 |
| Penn, RD | 1 |
| el Newihi, H | 1 |
| Dooley, CP | 1 |
| Saad, C | 1 |
| Staples, J | 1 |
| Zeidler, A | 1 |
| Valenzuela, JE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Plasma Exchange for Autoimmune Autonomic Failure[NCT00359346] | 3 participants | Observational | 2006-07-14 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for bethanechol and Chronic Disease
| Article | Year |
|---|---|
Chronic pulmonary aspiration in children.
Topics: Bethanechol; Bethanechol Compounds; Bronchoscopy; Child; Chronic Disease; Diet Therapy; Gastric Acid | 1993 |
Drug pumps for treatment of neurologic diseases and pain.
Topics: Alzheimer Disease; Baclofen; Bethanechol; Bethanechol Compounds; Catheters, Indwelling; Chronic Dise | 1985 |
6 other studies available for bethanechol and Chronic Disease
| Article | Year |
|---|---|
Dynamic remodeling of the guinea pig intrinsic cardiac plexus induced by chronic myocardial infarction.
Topics: Angiotensin II; Animals; Axons; Bethanechol; Chronic Disease; Guinea Pigs; Heart; In Vitro Technique | 2014 |
Neurogenic bladder and chronic urinary retention associated with MDMA abuse.
Topics: Adult; Amphetamine-Related Disorders; Anti-Infective Agents, Urinary; Bethanechol; Central Nervous S | 2008 |
Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT(3) pathways.
Topics: Adult; Bethanechol; Catheterization; Chronic Disease; Colon; Constipation; Duodenum; Female; Gastroi | 2002 |
Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor.
Topics: Adrenergic alpha-Agonists; Aged; Autoantibodies; Autoimmune Diseases; Autonomic Nervous System; Auto | 2002 |
The functional effects of long-term outlet obstruction on the rabbit urinary bladder.
Topics: Adenosine Triphosphate; Animals; Bethanechol; Bethanechol Compounds; Chronic Disease; In Vitro Techn | 1990 |
Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy.
Topics: Adult; Amino Acids; Bethanechol; Bethanechol Compounds; Cholecystokinin; Chronic Disease; Diabetes M | 1988 |